By Deena Beasley and Sneha S K Oct 29 (Reuters) – Bristol Myers Squibb raised its full-year revenue forecast on Thursday, citing strong sales of its newer medicines, but lowered its 2026 earnings per
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Nathan Gomes and Nandan Mandayam Oct 29 (Reuters) - Caterpillar stuck to its annual…
NEW YORK, Oct 29 (Reuters) - The US sued Google for failing to restore a…
Oct 29 (Reuters) - Shell PLC: * SHELL CEO SAYS MAKING GOOD PROGRESS ON RESOURCE…
VIDEO SHOWS: SLACKLINER FLORIAN ZOLLER'S HIGHLINE WORLD RECORD SHOWS: TYROL, AUSTRIA (RECENT) (QUATTRO MEDIA) 1.…
By Juveria Tabassum Oct 29 (Reuters) - Hershey on Thursday warned that increased pressure on…
By Aditya Soni and Deborah Mary Sophia Oct 29 (Reuters) - Cash flow is king…